<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">04066</article-id><article-id pub-id-type="doi">10.7554/eLife.04066</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-16738"><name><surname>Chen</surname><given-names>Guo-Yun</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16778"><name><surname>Brown</surname><given-names>Nicholas K</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16779"><name><surname>Wu</surname><given-names>Wei</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16780"><name><surname>Khedri</surname><given-names>Zahra</given-names></name><aff><addr-line><named-content content-type="department">Department of Chemistry</named-content></addr-line>, <institution>Unversity of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16781"><name><surname>Yu</surname><given-names>Hai</given-names></name><aff><addr-line><named-content content-type="department">Department of Chemistry</named-content></addr-line>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16782"><name><surname>Chen</surname><given-names>Xi</given-names></name><aff><addr-line><named-content content-type="department">Department of Chemistry</named-content></addr-line>, <institution>University of California, Davis</institution>, <addr-line><named-content content-type="city">Davis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16783"><name><surname>van de Vlekkert</surname><given-names>Diantha</given-names></name><aff><addr-line><named-content content-type="department">Department of Genetics</named-content></addr-line>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16784"><name><surname>D'Azzo</surname><given-names>Alessandra</given-names></name><aff><addr-line><named-content content-type="department">Department of Genetics</named-content></addr-line>, <institution>St Jude Children's Research Hospital</institution>, <addr-line><named-content content-type="city">Memphis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16785"><name><surname>Zheng</surname><given-names>Pan</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16491"><name><surname>Liu</surname><given-names>Yang</given-names></name><aff><addr-line><named-content content-type="department">Center for Cancer and Immunology Research</named-content></addr-line>, <institution>Children's National Medical Center</institution>, <addr-line><named-content content-type="city">Washington, DC</named-content></addr-line>, <country>United States</country><email>yaliu@cnmc.org</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11686"><name><surname>Cao</surname><given-names>Xuetao</given-names></name><role>Reviewing editor</role><aff><institution>Zhejiang University School of Medicine</institution>, <country>China</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>09</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e04066</elocation-id><history><date date-type="received"><day>17</day><month>07</month><year>2014</year></date><date date-type="accepted"><day>28</day><month>08</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Chen et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Chen et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Both pathogen- and tissue damage-associated molecular patterns induce inflammation through toll-like receptors (TLRs), while sialic acid-binding immunoglobulin superfamily lectin receptors (Siglecs) provide negative regulation.  Here we report extensive and direct interactions between these pattern recognition receptors.  The promiscuous TLR binders were human SIGLEC-5/9 and mouse Siglec-3/E/F. Mouse Siglec-G did not show appreciable binding to any TLRs tested.  Correspondingly, <italic>Siglece</italic> deletion enhanced dendritic cell responses to all microbial TLR ligands tested, while <italic>Siglecg</italic> deletion did not affect the responses to these ligands. TLR4 activation triggers Neu1 translocation to cell surface to disrupt TLR4:Siglec-E interaction.  Conversely, sialidase inhibitor Neu5Gc2en prevented TLR4 ligand-induced disruption of TLR4:Siglec E/F interactions.  Absence of <italic>Neu1</italic> in hematopoietic cells or systematic treatment with sialidase inhibitor Neu5Gc2en protected mice against endotoxemia.  Our data raised an intriguing possibility of a broad repression of TLR function by Siglecs and a sialidase-mediated de-repression that allows positive feedback of TLR activation during infection.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (312-13-05) of the The Children's National Medical Center. Every effort was made to minimize suffering</p></fn></fn-group></back></article>